Compile Data Set for Download or QSAR
Report error Found 134 Enz. Inhib. hit(s) with all data for entry = 13221
TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767642(6-chloro-7-fluoro-2-(5-fluoro- 4H-1,2,4-triazol-3-...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767641(1-(5-(6-chloro-7-fluoro-5- methoxy-3-(1H-pyrazol-4...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767606(ethyl 5-(6,7-dichloro-3-(1H- pyrazol-4-yl)-1H-indo...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767588(6-chloro-7-fluoro-2-(5-fluoro- 4H-1,2,4-triazol-3-...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767607(5-(6,7-dichloro-3-(1H-pyrazol- 4-yl)-1H-indol-2-yl...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767666(2-(5-(6-chloro-7-fluoro-5- methoxy-1-methyl-3-(1H-...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767663(1-(5-(6-chloro-7-fluoro-5- methoxy-3-(1H-pyrazol-4...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767594(6,7-dichloro-2-(5-(1,1- difluoro-2-methoxyethyl)-4...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767657(6-chloro-2-(5-(1,1-difluoro-2- methoxyethyl)-4H-1,...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767596(6,7-dichloro-3-(1H-pyrazol-4- yl)-2-(5-(trifluorom...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767592(1-(5-(6,7-dichloro-3-(1H- pyrazol-4-yl)-1H-indol-2...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767650(6-chloro-2-(5-(1,1-difluoro-2- methoxyethyl)-4H-1,...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767681(1-(5-(6-chloro-7-fluoro-3- (1H-imidazol-1-yl)-5- m...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767651(6-chloro-2-(5-(1,1- difluoroethyl)-4H-1,2,4- triaz...)
Affinity DataIC50: 30nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767649(6-chloro-2-(5-(1,1-difluoro-2- methoxyethyl)-4H-1,...)
Affinity DataIC50: 31nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767644(1-(5-(6-chloro-7-fluoro-5- methoxy-1-methyl-3-(1H-...)
Affinity DataIC50: 32nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767589(6-chloro-7-fluoro-5-methoxy- 3-(1H-pyrazol-4-yl)-2...)
Affinity DataIC50: 33nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767652(6-chloro-2-(5-(1,1- difluoroethyl)-4H-1,2,4- triaz...)
Affinity DataIC50: 33nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767683(1-(5-(6-chloro-7-fluoro-3- (1H-imidazol-1-yl)-5- m...)
Affinity DataIC50: 37nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767653(2-(5-(6-chloro-7-fluoro-5- methoxy-1-methyl-3-(1H-...)
Affinity DataIC50: 38nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767617(6-chloro-3-(1H-pyrazol-4-yl)- 2-(5-(trifluoromethy...)
Affinity DataIC50: 38nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767654(6-chloro-7-fluoro-2-(5-(1- fluoro-2-methoxyethyl)-...)
Affinity DataIC50: 39nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767664(1-(5-(6-chloro-7-fluoro-5- methoxy-1-methyl-3-(1H-...)
Affinity DataIC50: 39nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767674(6-chloro-2-(5-(1,1-difluoro-2- methoxyethyl)-4H-1,...)
Affinity DataIC50: 40nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767645(N-(5-(6-chloro-7-fluoro-5- methoxy-1-methyl-3-(1H-...)
Affinity DataIC50: 41nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767672(6-chloro-7-fluoro-2-(5-fluoro- 4H-1,2,4-triazol-3-...)
Affinity DataIC50: 43nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767655(6-chloro-7-fluoro-2-(5-(1- fluoroethyl)-4H-1,2,4-t...)
Affinity DataIC50: 44nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767601(6-chloro-7-fluoro-3-(1H- pyrazol-4-yl)-2-(5- (trif...)
Affinity DataIC50: 44nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767587(5-(6-chloro-7-fluoro-5- methoxy-1-methyl-3-(1H- py...)
Affinity DataIC50: 46nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767623(5-(6-chloro-7-fluoro-3-(1H- imidazol-1-yl)-5-metho...)
Affinity DataIC50: 48nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767597(6,7-dichloro-1-methyl-3-(1H- pyrazol-4-yl)-2-(5- (...)
Affinity DataIC50: 48nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767615(5-(6-chloro-5-methoxy-3-(1H- pyrazol-4-yl)-1H-indo...)
Affinity DataIC50: 49nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767648(1-(5-(6-chloro-7-fluoro-5- methoxy-1-methyl-3-(1H-...)
Affinity DataIC50: 52nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767647(2-((5-(6-chloro-7-fluoro-5- methoxy-1-methyl-3-(1H...)
Affinity DataIC50: 54nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767639(6-chloro-2-(5-(1,1-difluoro-2- methoxyethyl)-4H-1,...)
Affinity DataIC50: 55nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767640(6-chloro-7-fluoro-3-(1H- imidazol-1-yl)-5-methoxy-...)
Affinity DataIC50: 56nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767629((5-(6-chloro-7-fluoro-3-(1H- imidazol-1-yl)-5-meth...)
Affinity DataIC50: 56nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767680(2-(5-(6-chloro-7-fluoro-3- (1H-imidazol-1-yl)-5- m...)
Affinity DataIC50: 56nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767634(6-chloro-7-fluoro-3-(1H- imidazol-1-yl)-5-methoxy-...)
Affinity DataIC50: 57nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767628((5-(6-chloro-7-fluoro-3-(1H- imidazol-1-yl)-5-meth...)
Affinity DataIC50: 58nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767646(N-(5-(6-chloro-7-fluoro-5- methoxy-1-methyl-3-(1H-...)
Affinity DataIC50: 60nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767678(2-(5-(6-chloro-7-fluoro-3- (1H-imidazol-1-yl)-5- m...)
Affinity DataIC50: 60nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767625(5-(6-chloro-7-fluoro-3-(1H- imidazol-1-yl)-5-metho...)
Affinity DataIC50: 61nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767627((5-(6-chloro-7-fluoro-3-(1H- imidazol-1-yl)-5-meth...)
Affinity DataIC50: 61nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767656(6-chloro-7-fluoro-2-(5-(1- fluoroethyl)-4H-1,2,4-t...)
Affinity DataIC50: 61nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767626((5-(6-chloro-7-fluoro-3-(1H- imidazol-1-yl)-5-meth...)
Affinity DataIC50: 63nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767669((R)-1-(5-(6-chloro-7-fluoro-3- (1H-imidazol-1-yl)-...)
Affinity DataIC50: 63nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767667(1-(5-(6-chloro-7-fluoro-3- (1H-imidazol-1-yl)-5- m...)
Affinity DataIC50: 63nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767684(6-chloro-2-(5-(2,2-difluoro-1- methoxyethyl)-4H-1,...)
Affinity DataIC50: 64nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

TargetCyclic GMP-AMP synthase(Human)
Novartis

US Patent
LigandPNGBDBM767685(2-(5-(1-(1H-imidazol-1-yl)-2- methoxyethyl)-4H-1,2...)
Affinity DataIC50: 65nMAssay Description:A reagent buffer was prepared in filtered and autoclaved water according to the following:50 mM Tris-buffer pH 7.5 (1 M Tris-buffer pH 7.5, Invitroge...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
12/11/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 134 total ) | Next | Last >>
Jump to: